(S)-Tedizolid
Catalog No. A14965
Torezolid是恶唑烷酮类药物的II期临床试验，用于复杂的皮肤和皮肤结构感染（cSSSI），包括由耐甲氧西林的金黄色葡萄球菌（MRSA）引起的感染。
| Catalog Num | A14965 |
|---|---|
| M. Wt | 370.34 |
| Formula | C17H15FN6O3 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1431699-67-0 |
| Synonyms | |
| SMILES | CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F |
Torezolid是恶唑烷酮类药物的II期临床试验，用于复杂的皮肤和皮肤结构感染（cSSSI），包括由耐甲氧西林的金黄色葡萄球菌（MRSA）引起的感染。
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 27 mL | 135.01 mL | 270.02 mL |
| 0.5 mM | 5.4 mL | 27 mL | 54 mL |
| 1 mM | 2.7 mL | 13.5 mL | 27 mL |
| 5 mM | 0.54 mL | 2.7 mL | 5.4 mL |
*The above data is based on the productmolecular weight 370.34. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.